Literature DB >> 31006652

Psychopathological disorders in Prader-Willi syndrome.

Martí Guinovart1, Ramón Coronas2, Assumpta Caixàs3.   

Abstract

Prader-Willi syndrome is a genetic disorder caused by chromosomal changes in segment 15q11-q13 including cognitive, mental, and behavioral symptoms, as well as a specific physical phenotype. Both the most common psychopathological changes (intellectual disability, obsessions, impulsivity, autism spectrum disorders, self-injuries) and the main psychiatric comorbidities (affective disorders, psychosis, obsessive-compulsive disorder, autism spectrum disorder) are characterized by a great heterogeneity, which warrants the need for better identification of their frequency and clinical signs. In addition to its effects on body compositionand hypotony, growth hormone has been shown to be useful for regulating patient behavior, and psychoactive drugs are also an option. Other alternatives have shown promising results in experimental trials. Adequate understanding of the psychopathology associated to Prader-Willi syndrome would allow for improving clinical approach, symptom identification, detection of comorbidities, and administration of more effective treatments, leading to better clinical outcomes.
Copyright © 2019 SEEN y SED. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Comorbidity; Comorbilidad; Prader-Willi syndrome; Psicopatología; Psychopathology; Síndrome de Prader-Willi

Mesh:

Substances:

Year:  2019        PMID: 31006652     DOI: 10.1016/j.endinu.2019.03.004

Source DB:  PubMed          Journal:  Endocrinol Diabetes Nutr (Engl Ed)        ISSN: 2530-0180            Impact factor:   1.417


  6 in total

1.  A pro-inflammatory phenotype is associated with behavioural traits in children with Prader-Willi syndrome.

Authors:  Maja Krefft; Dorota Frydecka; Gil Zalsman; Małgorzata Krzystek-Korpacka; Robert Śmigiel; Katarzyna Gębura; Katarzyna Bogunia-Kubik; Błażej Misiak
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-06-03       Impact factor: 4.785

2.  Metabolic Parameters in Patients with Prader-Willi Syndrome and DiGeorge Syndrome with Respect to Psychopathological Manifestation.

Authors:  Maja Krefft; Dorota Frydecka; Robert Śmigiel; Błażej Misiak
Journal:  Neuropsychiatr Dis Treat       Date:  2020-02-14       Impact factor: 2.570

3.  Social Responsiveness and Psychosocial Functioning in Adults with Prader-Willi Syndrome.

Authors:  Meritxell Fernández-Lafitte; Jesus Cobo; Ramon Coronas; Isabel Parra; Joan Carles Oliva; Aida Àlvarez; Susanna Esteba-Castillo; Olga Giménez-Palop; Diego J Palao; Assumpta Caixàs
Journal:  J Clin Med       Date:  2022-03-05       Impact factor: 4.241

4.  One Year of Recombinant Human Growth Hormone Treatment in Adults with Prader-Willi Syndrome Improves Body Composition, Motor Skills and Brain Functional Activity in the Cerebellum.

Authors:  Laia Casamitjana; Laura Blanco-Hinojo; Olga Giménez-Palop; Jesús Pujol; Gerard Martínez-Vilavella; Susanna Esteba-Castillo; Rocío Pareja; Valentín Freijo; Laura Vigil; Joan Deus; Assumpta Caixàs
Journal:  J Clin Med       Date:  2022-03-25       Impact factor: 4.241

5.  Caring and living with Prader-Willi syndrome in Italy: integrating children, adults and parents' experiences through a multicentre narrative medicine research.

Authors:  Letizia Ragusa; Antonio Crinò; Graziano Grugni; Luigi Reale; Alessandra Fiorencis; Maria Rosaria Licenziati; Maria Felicia Faienza; Malgorzata Wasniewska; Maurizio Delvecchio; Adriana Franzese; Irene Rutigliano; Paola Fusilli; Domenico Corica; Giuseppina Campana; Donatella Greco; Mariangela Chiarito; Michele Sacco; Silvia Toscano; Maria Giulia Marini
Journal:  BMJ Open       Date:  2020-08-06       Impact factor: 2.692

6.  Multidimensional Evaluation of Awareness in Prader-Willi Syndrome.

Authors:  Jesús Cobo; Ramón Coronas; Esther Pousa; Joan-Carles Oliva; Olga Giménez-Palop; Susanna Esteba-Castillo; Ramon Novell; Diego J Palao; Assumpta Caixàs
Journal:  J Clin Med       Date:  2021-05-07       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.